Principal investigator: Guo Gang
SclerodermaAnkylosing spondylitisRheumatoid arthritisSjögren's syndromeLupusPolymyositis / dermatomyositis
The Rheumatic Immune Disease specialty began in 1992. Over more than 20 years of exploration and innovation, the department has, by incomplete statistics, published over 100 papers in provincial-level or higher journals and 4 medical monographs, taken part in 2 national new-drug research fund projects and nearly 10 provincial research projects, and won a Hebei Science and Technology Progress Second Prize, 2 first prizes of the Hebei Provincial Chinese Medicine Association Science and Technology Award, 2 first prizes of the Hebei Provincial Health Commission Science and Technology Progress Award and a Shijiazhuang Science and Technology Progress First Prize.
The department has 100 beds and 36 medical staff, including 6 chief physicians and 3 associate chief physicians. It emphasizes integrated Chinese and Western medicine, parallel development of medicine and pharmaceuticals, and combining clinical and experimental research. Equipment includes a German-made plasma exchange device, a microcomputer-controlled steam therapy machine, a whole-body medicinal bath, a laser therapy instrument, a paraffin wax therapy machine, an iontophoresis machine, a compressed nebulizer and a long-wave ultraviolet skin treatment system.
It is recognized as:
- China Association for Promotion of Medicine Rheumatic Immune Disease Clinical Research Base
- Hebei Province Key Chinese Medicine Specialty Construction Unit
- Member unit of the International Scleroderma Clinical and Research Alliance (inSCAR)
- Shijiazhuang Municipal Chinese Medicine Rheumatic Immune Disease Clinical Medical Research Center
Signature therapies: a systematic comprehensive foot-treatment sequential intensive method for ankylosing spondylitis and rheumatoid arthritis; three-syndrome differentiation, three-combination staged treatment of pulmonary fibrosis; a three-stage skin-softening regimen and thoracic duct drainage for scleroderma; an integrated rehabilitation unit program for polymyositis/dermatomyositis; parotid gland perfusion for Sjögren's syndrome; and combined internal and external treatment for Behçet's disease. It also uses herbal bathing, iontophoresis, herbal packs, topical ointments and large moxibustion, and has developed more than 30 unique in-hospital preparations that help prevent relapse and improve quality of life.
About the principal investigator: Guo Gang
Publications and projects: edited 1 monograph, contributed to 9 others and published 42 papers; leads 1 Ministry of Science and Technology international cooperation project and 1 National Natural Science Foundation general project, and has led 4 provincial projects. Awards include 2 first prizes of the Hebei Provincial Chinese Medicine Association Science and Technology Award and 2 first prizes of the Shijiazhuang Science and Technology Progress Award.
Expertise: integrated Chinese and Western diagnosis and treatment of scleroderma, Sjögren's syndrome, polymyositis/dermatomyositis, arthritis, lupus erythematosus, Behçet's disease, pulmonary fibrosis and immune-related skin diseases, combining collateral disease theory with traditional bi syndrome theory.
Guo Gang
Chief TCM Physician · Professor · Master's Supervisor
Deputy Director of Hebei Yiling Hospital and Director of Rheumatology Department 2.
- Standing committee member, Rheumatology Committee, China Association of Chinese Medicine
- Chair, Hebei Provincial Chinese Medicine Rheumatic and Bone Disease Committee; Deputy Chair, Hebei Provincial Integrated Chinese-Western Medicine Rheumatology Committee
- Inaugural Executive Committee member, International Scleroderma Research Collaborative Network (inSCAR)
- Third national batch of Outstanding Chinese Medicine Trainees; Famous Young Chinese Medicine Physician of Shijiazhuang
- Academic advisor, Beijing-Tianjin-Hebei Rheumatology Community; editorial board member and peer reviewer, Rheumatism and Arthritis
Planning a clinical trial with us?
Contact the Drug Clinical Trial Institution Office, 4th floor, Outpatient Building, 385 Xinshi North Road, Shijiazhuang. Reception hours: weekdays 8:30–11:30 and 14:00–17:00.